Global and China Industrial Enzyme Industry Report, 2012-2014
  • Nov./2012
  • Hard Copy
  • USD $1,900
  • Pages:68
  • Single User License
    (PDF Unprintable)       
  • USD $1,800
  • Code: ZYM037
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,800
  • Hard Copy + Single User License
  • USD $2,100
Industrial enzyme which refers to the enzyme preparation used for industrial purposes can be applied to detergent, animal feed, bread, brewing (beer, wine, etc.), papermaking, textile, bio-ethanol and so forth; especially, food & brewing, feed and detergent are the most commonly application fields, and they consume about 75% of industrial enzyme together.

The industrial enzyme market size has been expanding in recent years with the improvement of R&D technology and the extension of application range. From 2001-2011, the global industrial enzyme market scale presented a CAGR of 6.8%, and in 2011 the global market valued USD3.5 billion, with a year-on-year growth rate of 6.1%. Through numerous mergers and acquisitions, the global industrial enzyme market concentration degree has been gradually raised. In 2011, Novozymes and DuPont (DuPont acquired Genencor) enjoyed market share of 47% and 21% respectively.

Through several decades of development, China has become an important production base of industrial enzyme, and its market size accounts for about 10% of the global size. Judging from Chinese economic situation and domestic demand, the industrial enzyme market of China is expected to embrace a faster growth rate of 10% or so than the global 6%-8% in the next three years, and it will reach at least RMB3 billion in 2014. Yet, foreign tycoons with patent monopoly and strong R&D capabilities have entered China in succession, while Chinese counterparts are lagged in R&D, therefore Chinese native enzyme preparation enterprises have weak competitiveness, and the Chinese market is still currently dominated by Novozymes, DuPont (Genencor) and other foreign brands.

However, in market segments like feedstuff, Chinese play, VTR, for example, occupy a significant position, with 16.5% share (by sales volume) in Chinese feed enzyme market in 2011. Meanwhile, local enterprises are not only increasing new products, but also striving to expand their production scale and enhance marketing; for instance, VTR invested the funds raised from IPO in “12,000 t/a Enzyme Preparation Project Phase II” in Inner Mongolia (early 2012); Hunan Hongyingxiang and Jinshi Development Zone signed an agreement for “300,000 standard tons/a Enzyme Preparation Project” (May, 2012). Therefore, based on local advantages, it is expected that Chinese companies will sweep more market shares.

The report covers the followings:

20120114.gif Status quo, regional distribution, competition pattern and prospect of global industrial enzyme industry;
20120114.gif Relevant policies, current situation, competitive landscape, import & export and prospect of Chinese industrial enzyme industry;
20120114.gif Impact of industrial enzyme downstream sectors like baked food, brewing, feedstuff and bio-ethanol in China;
20120114.gif Operation, enzyme preparation business and development prospect of 9 enzyme preparation suppliers at home and abroad (such as Novozymes, DuPont (Genencor), VTR, Youteer, etc.).

1 Overview of Industrial Enzyme 

2 Development of Global Industrial Enzyme Industry 
2.1 Status Quo
2.2 Regional Distribution
2.3 Competition Pattern
2.4 Development Prospect 

3 Development of China Industrial Enzyme Industry
3.1 Related Policies
3.2 Market 
3.3 Competitive Landscape
3.4 Import and Export
3.4.1 Import
3.4.2 Export
3.5 Development Outlook

4 Impact of Downstream on Chinese Enzyme Industry
4.1 Food Industry
4.1.1 Bakery
4.1.2 Condiments
4.2 Brewing Industry
4.2.1 Beer
4.2.2 Wine
4.2.3 Others
4.3 Detergent Industry
4.3 Feedstuff Industry
4.4 Papermaking and Textile Industry
4.4.1 Papermaking Industry
4.4.2 Textile Industry
4.5 Bio-ethanol Industry

5 Major Foreign Companies
5.1 Novozymes 
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure 
5.1.4 R&D Investment 
5.1.5 Enzyme Business
5.1.6 Development in China
5.2 Danisco (Genencor)
5.2.1 Profile
5.2.2 Operation
5.2.3 Development in China
5.3 DSM
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure 
5.3.3 Development in China
5.4 AB Enzymes
5.4.1 Profile
5.4.2 Operation
5.4.3 Development in China

6 Major Chinese Suppliers
6.1 Guangdong VTR
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Customers and Suppliers
6.1.5 Capacity, Output and Sales Volume
6.1.6 Costs and Prices
6.1.7 Prospect 
6.2 Hunan Youteer 
6.2.1 Profile
6.2.2 Operation and Development Forecast 
6.3 Shandong Longda
6.3.1 Profile
6.3.2 Operation and Development Forecast 
6.4 KDN Biotech
6.4.1 Profile
6.4.2 Operation and Development Forecast 
6.5 Sunson
6.5.1 Profile
6.5.2 Operation and Development Forecast 

Global Industrial Enzyme Market Size and YoY Growth Rate, 2008-2011
Global Industrial Enzyme Market Structure (by Application)
Regional Distribution of Global Enzyme Preparation, 2011
Market Share of Global Industrial Enzyme Enterprises, 2011
Global Industrial Enzyme Market Size, 2011-2014E
Major Enzyme Enterprises and Their Competitive Edges in China
Enzyme Import Volume and Value in China, 2009-2012 
Average Enzyme Import Price in China, 2009-2012 
Enzyme Import Volume (by type) in China, Jan.-Aug. 2012
Enzyme Import Volume and Value (by Country and Region) in China, Jan.-Aug. 2012
Enzyme Export Volume and Value in China, 2009-2012
Average Enzyme  Export Price in China, 2009-2012
Enzyme Export Volume and Value (by Country and Region) in China, Jan.-Aug. 2012
Some New Industrial Enzyme Projects in China, by Aug. 2012
Pastry Output and YoY Growth Rate in China, 2007-2011
Revenue and Total Profit of Chinese Bakery Industry, 2008-2012 
Revenue and Total Profit of China’s Condiment and Fermentation Products Industry, 2008-2012
Soy Sauce Output and YoY Growth Rate in China, 2007-2012
Application of Enzyme Products in Beer Brewing
Beer Output and YoY Growth Rate in China, 2007-2012
Beer Sales Volume and Sales-output Ratio in China, 2007-2012
Revenue and Total Profit of China Beer Industry, 2008-2012
Wine Output and YoY Growth Rate in China, 2007-2012
Revenue and Total Profit of China Wine Industry, 2007-2012
Detergent Output in China, 2007-2012
Feedstuff Output (by Type) in China, 2011
Feedstuff Output (by Category) in China, 2011
Output of Pulp, Machine-made Paper and Paperboard in China, 2007-2012
Revenue of Pulp, Machine-made Paper and Paperboard in China, 2007-2012
Output of Cloth, Yarn and Silk Fabrics in China, 2008-2012
Revenue of China Textile Industry, 2007-2012
Revenue and EBIT of Novozymes, 2007-2011 
Investment Funds and ROIC of Novozymes, 2007-2011
Revenue of Novozymes (by Applicantion),  2011
Revenue of Novozymes (by Region) , 2011
R&D Investment and Its Proportion in Revenue of Novozymes, 2007-2011
Industrial Enzyme Revenue of Novozymes (by Product) , 2007-2011
Danisco’s Companies in China 
DSM’s Revenue and Operating Profit, 2010-2011
DSM’s Revenue (by Business), 2010-2011 
DSM’s Revenue (by Application), 2010-2011
DSM’s Revenue (by Origin), 2010-2011
DSM’s Revenue (by Sales Region), 2010-2011
Revenue and Profit of ABF Additive Business, 2009-2011
VTR’s Revenue and Profit , 2009-2011
VTR’s Enzyme Preparation Revenue (by Product or Dosage Form), 2009-2011
VTR’s Revenue (by Sales Model) , 2009-2011 
Namelist and Revenue Contribution of VTR’s Top 5 Clients, 2009-2011
Name list and Procurement of VTR’s Top 5 Suppliers, 2009-2011
VTR’s Enzyme Preparation Output (by Base), 2009-2011
VTR’s Enzyme Preparation Capacity, Output and Sales Volume (by Dosage Form), 2009-2011
VTR’s Enzyme Preparation Output and Sales Volume (by Product), 2009-2011
Procurement Quantity and Price of VTR’s Raw Materials, 2009-2011
Quantity and Proportion of VTR’s Self-produced and Purchased Enzyme Sources, 2009-2011
VTR’s Raw Material Procurement Capital and Proportion, 2009-2011
VTR’s Enzyme Preparation Price (by Product or Dosage Form), 2009-2011
VTR’s Product R&D Progress, by end 2011
VTR’s R&D Cost and % in Revenue, 2009-2011
VTR’s IPO Projects and Funds, 2012
VTR’s Revenue and Net Income, 2011-2014E
Revenue and Net Income of Hunan Youteer, 2008-2011
Revenue and Net Income of Hunan Youteer, 2011-2014E
Events of KDN Biotech, 2011-2012
Sunson's R&D Centers and Production Bases
Operating Revenue and Operating Income of Sunson, 2008-2009

China Vacuum Blood Collection Industry Report, 2014-2017

The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it int...

China Pharmaceutical Excipients Industry Report, 2014-2017

Pharmaceutical excipients refer to adjuvants and additives used for production of pharmaceuticals and compounding of prescriptions. In addition to active ingredients, pharmaceutical excipients are als...

China Recombinant Protein Drug Industry Report, 2014-2017

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein dru...

China Heparin Industry Report, 2014-2017

As the world's major heparin API producer and exporter, China boasts enormous raw materials, which provides a strong support for the production of China’s heparin products. In 2013, the live pigs rais...

Global and China Monoclonal Antibody Industry Report, 2014-2019

Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded USD 80 billion in 2013, still one of biot...

Global and China DNA Sequencing Industry Research Report, 2014-2017

DNA sequencing is the process of reading nucleotide bases in a specific DNA molecule, that is to say determining the arrangement mode of adenine, thymine, cytosine, and guanine. It can be applied in a...

Global and China Stem Cell Industry Report, 2014-2017

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatmen...

China Human Vaccine Industry Report, 2014-2017

Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China’s human vaccine lot release volume grew by 4.9% from a year earlie...

China Blood Product Industry Report, 2014-2017

Plasma resource reserves and control are crucial to the development of blood products industry. Although the closure of 16 plasma collection stations in Guizhou in 2011 didn’t cause major disruption t...

China Animal Vaccine Industry Report, 2013-2016

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main ...

China Contract Research Organization (CRO) Industry Report, 2013-2016

China CRO industry has developed rapidly in recent years, registering a CAGR of 27.2% during 2007-2013, of which the market size reached RMB 36 billion in 2013, occupying 10% of global market share. ...

Global and China Biodegradable Plastics Industry Report, 2013-2016

Global biodegradable plastic production and demand have grown rapidly in recent years, and the capacity reached 1-1.5 million t/a in 2012-2013. Among dozens of biodegradable plastic varieties develope...

Global and China Industrial Enzyme Industry Report, 2014-2016

In 2007-2013, the global industrial enzyme market size grew at the CAGR of 5.7%, reaching USD4.04 billion in 2013, 1.4 times that in 2007. The global industrial enzyme market is monopolized by a small...

China Heparin Industry Report, 2013-2015

Since the small intestines of pigs (raw materials for production of heparin) in China are abundant (the pig slaughtering volume in China approximates 50% of globe’s total) and heparin APIs are gradual...

China Lactic Acid and Derivative Industry Report, 2013

China’s lactic acid capacity and output continued to grow at the respective CAGR of 22.7% and 28.7% in 2007-2011. But limited by market demand, the annual output of most vendors was below their design...

China Human Vaccine Industry Report, 2012-2015

In the wake of China's economic growth and enhanced disease prevention awareness, Chinese human vaccine market has been expanding. In 2012, Chinese human vaccine market valued RMB10.5 billion with the...

China Blood Product Industry Report, 2012-2015

Plasma is a key raw material of the blood product industry. In August 2011, China shut down 16 plasma stations in Guizhou, resulting in a decrease of 15% in the plasma volume of the year. However, due...

China Animal Vaccine Industry Report, 2012-2015

In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Be...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号